as on November 7, 2025 at 10:38 pm IST
Day's Low
Day's High
1.21%
Downside
4.24%
Upside
52 Week's Low
52 Week's High
52.32%
Downside
93.08%
Upside
Check Neogenomics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.3B
EPS (TTM)
0.0992
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.31%
PE Ratio (TTM)
-26.79
Industry PE ratio
8.355964912280701
PEG Ratio
3.02
EBITDA
-3.4M
Revenue (TTM)
709.2M
Profit Margin
-16.00%
Return On Equity TTM
-12.99%
Track how Neogenomics, Inc. P/E has moved over time to understand its valuation trends.
Neogenomics, Inc. in the last 5 years
Lowest (-173.72x)
December 31, 2024
Today (-26.79x)
November 7, 2025
Industry (8.36x)
November 7, 2025
Highest (-15.52x)
September 30, 2022
Today’s Price to Earnings Ratio: -26.79x
Compare market cap, revenue, PE, and other key metrics of Neogenomics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.3B | -74.42% | -26.79 | -16.00% | |
| BUY | $57.5B | 49.29% | 57.16 | 24.65% | |
| BUY | $213.3B | 7.26% | 32.79 | 15.02% | |
| BUY | $41.6B | 31.06% | 34.29 | 17.97% | |
| BUY | $35.9B | 22.99% | 29 | 8.07% |
The Neogenomics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neogenomics, Inc. investment value today
Current value as on today
₹67,686
Returns
Returns from Neogenomics, Inc. Stock
Dollar Returns*
₹5,107 (+5.11%)
Based on 17 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Neogenomics, Inc.. Average target price of $13.06
Get share price movements and forecasts by analysts on Neogenomics, Inc..
What analysts predicted
24.2%UPSIDE
Target Price
$13.06
Current Price
$9.9
Analyzed by
17 Analysts
Target
$13.06
Neogenomics, Inc. target price $13.06, a slight upside of 24.2% compared to current price of $9.9. According to 17 analysts rating.
Search interest for Neogenomics, Inc. Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 16 October
Thu, 11:35 AM
-NeoGenomics shares climbed over 8% this week, reflecting renewed investor interest amid long-term challenges.
Thu, 01:24 PM
-NeoGenomics shares rose 6.3% to $9.97, driven by positive investor expectations and upcoming clinical data presentations.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -45.09M → -27.12M (in $), with an average increase of 66.2% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 168.03M → 187.79M (in $), with an average increase of 5.4% per quarter
Price Rise
![]()
In the last 7 days, NEO stock has moved up by 6.4%
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 85.3% return, outperforming this stock by 38.8%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 52.97% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 64.8% return, outperforming this stock by 99.1%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 47.03% of holdings in Sep 2025 quarter
Price Dip
![]()
In the last 1 year, NEO stock has moved down by -53.0%
| Organisation | Neogenomics, Inc. |
| Headquarters | 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 |
| Industry | Health Services |
| CEO | Mr. Anthony P. Zook |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Alicia C. Olivo | Executive VP of Business Development, General Counsel & Corporate Secretary |
Mr. Hutan Hashemi J.D. | Chief Compliance Officer |
Mr. Gary Passman | Chief People & Culture Officer |
Ms. Kendra Sweeney | Vice President of Investor Relations & Communications |
Mr. Kareem M. Saad | Head of Strategy, Business Development & Transformation |
Mr. Anthony P. Zook | CEO & Director |
Mr. Warren Stone | President & COO |
Mr. Jeffrey S. Sherman M.B.A. | Chief Financial Officer |
Ms. Elizabeth A. Floegel | Chief Digital & Information Officer |
Mr. Gregory D. Aunan | Senior VP & Chief Accounting Officer |
Neogenomics, Inc. share price today is $9.9 as on . Neogenomics, Inc. share today touched a day high of $10.32 and a low of $9.78.
Neogenomics, Inc. share touched a 52 week high of $19.12 on and a 52 week low of $4.72 on . Neogenomics, Inc. stock price today i.e. is trending at $9.9,which is 48.21% down from its 52 week high and 109.75% up from its 52 week low.
Neogenomics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Neogenomics, Inc. (NEO) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Neogenomics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neogenomics, Inc. share’s latest price of $9.9 as on November 7, 2025 at 10:38 pm IST, you will get 1.0101 shares of Neogenomics, Inc.. Learn more about
fractional shares .
Neogenomics, Inc. stock has given -74.42% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?